SANA
SANA
NASDAQ · Biotechnology

Sana Biotechnology Inc

$3.11
-0.06 (-1.89%)
As of Mar 22, 10:12 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +1,188.7% upside
Low Target $23.55
Average Target $40.08
High Target $57.48
Current Price $3.11
Current
$3.11
Target
$40.08
$23.55 $40.08 avg $57.48
Scenario Analysis
Bear Case
$23.55
657.2%
Low target
Base Case
$40.08
+1,188.7%
Avg target
Bull Case
$57.48
+1,748.2%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$6.55
-52.5% from high
52-Week Low
$1.26
+146.8% from low
Target vs 52W High
$40.08
+511.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%